Transcatheter aortic valve implantation combined with other heart interventions: current status and future perspectives

Abstract

Transcatheter aortic valve implantation is a well-proven effective treatment option for patients with severe symptomatic aortic valve stenosis requiring valve replacement in all risk classes. Frequently, however, other concomitant cardiovascular conditions demanding intervention are present, and a combined approach is required. Here, we discuss some of the most frequent combined settings. The decision about which approach (staged or simultaneous) is more suitable for each patient needs to be based on individual characteristics and clinical, anatomical, and procedure-related factors.

Keywords

Transcatheter aortic valve implantation / combined procedure / heart valve disease / percutaneous coronary intervention / outcomes

References

[1] Leon MB,Mack MJ,Moses JW.Transcatheter aortic-valve implantation in patients who cannot undergo surgery..N Engl J Med2010;363:1597-607

[2] Smith CR,Mack MJ,Moses JW.Transcatheter versus surgical aortic-valve replacement in high-risk patients..N Engl J Med2011;364:2187-98

[3] Gilard M,Iung B,Chevreul K.Registry of transcatheter aortic-valve implantation in high-risk patients..N Engl J Med2012;366:1705-15

[4] Paradis JM,Nazif T,Harjai K.Aortic stenosis and coronary artery disease: what do we know? What don’t we know? A comprehensive review of the literature with proposed treatment algorithms..Eur Heart J2014;35:2069-82

[5] Adams DH,Reardon MJ,Coselli JS.Transcatheter aortic-valve replacement with a self-expanding prosthesis..N Engl J Med2014;370:1790-8

[6] Leon MB,Mack MJ,Svensson LG.Transcatheter or surgical aortic-valve replacement in intermediate-risk patients..N Engl J Med2016;374:1609-20

[7] Reardon MJ,Popma JJ,Søndergaard L.Surgical or transcatheter aortic-valve replacement in intermediate risk patients..N Engl J Med2017;376:1321-31

[8] Mack MJ,Thourani VH,Kodali SK.Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients..N Engl J Med2019;380:1695-705

[9] Popma JJ,Yakubov SJ,Gada H.Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients..N Engl J Med2019;380:1706-15

[10] Baumgartner H,Bax JJ,Hamm C.ESC/EACTS Guidelines for the management of valvular heart disease: the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)..Eur Heart J2017;38:2739-91

[11] Yang Y,Huang BT,Pu XB.The safety of concomitant transcatheter aortic valve replacement and percutaneous coronary intervention: a systematic review and meta-analysis..Medicine (Baltimore)2017;96:e8919 PMCID:PMC5728783

[12] Penkalla A,Drews T,Dreysse S.Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach..Eur J Cardiothorac Surg2015;47:1083-9

[13] Li J,Nadeem F,Al-Kindi S.Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement..Catheter Cardiovasc Interv2019;93:545-52

[14] Blumenstein J,Liebetrau C,Kempfert J.Challenges of coronary angiography and intervention in patients previously treated by TAVI..Clin Res Cardiol2015;104:632-9

[15] Tang GHL,Gupta E,Patel N.Impact of initial evolut transcatheter aortic valve replacement deployment orientation on final valve orientation and coronary reaccess..Circ Cardiovasc Interv2019;12:e008044

[16] Ochiai T,Flint N,Patel V.TCT-683 variation in the timing of percutaneous coronary intervention and outcomes in patients undergoing transcatheter aortic valve replacement..J Am Coll Cardiol2019;74:B670

[17] Hutter A,Richter V,Hettich I.Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation..Ann Thorac Surg2013;95:77-84

[18] Webb JG,Humphries K,Altwegg L.Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis..Circulation2007;116:755-63

[19] Tzikas A,van Dalen BM,Geleijnse ML.Changes in mitral regurgitation after transcatheter aortic valve implantation..Catheter Cardiovasc Interv2010;75:43-9

[20] Barbanti M,Hahn RT,Boone RH.Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A..Circulation2013;128:2776-84

[21] Toggweiler S,Rodes-Cabau J,Lee M.Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation..J Am Coll Cardiol2012;59:2068-74

[22] Nombela-Franco L,Zahn R,Leon MB.Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis..Heart2015;101:1395-405

[23] Bedogni F,DeMarco F,Oreglia J.Interplay between mitral regurgitation and transcatheter aortic valve replacement with the CoreValve Revalving System: a multicenter registry..Circulation2013;128:2145-53

[24] Cortes C,Nombela-Franco L,Gutierrez-Ibanes E.Mitral regurgitation after transcatheter aortic valve replacement: prognosis, imaging predictors, and potential management..J Am Coll Cardiol Cardiovasc Interv2016;9:1603-14

[25] Taramasso M,Nietlispach F.TAVI and concomitant procedures: from PCI to LAA closure..EuroIntervention2015;11:W96-100

[26] Ruel M,Price J,Burwash IG.Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement..Circulation2006;114:I541-6

[27] Almasood A,El-Shurafa H,Al Kasab S.The change in mitral regurgitation severity after transcatheter aortic valve implantation..J Saudi Heart Assoc2015;27:10-7 PMCID:PMC4274302

[28] Stähli BE,Leistner DM,Lauten A.Transcatheter aortic valve replacement and concomitant mitral regurgitation..Front Cardiovasc Med2018;5:74 PMCID:PMC6018074

[29] Ando T,Briasoulis A,Slovut DP.A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions..Catheter Cardiovasc Interv2018;91:124-34

[30] Veronesi F,Sugeng L,Caiani EG.A study of functional anatomy of aortic-mitral valve coupling using 3D matrix transesophageal echocardiography..Circ Cardiovasc Imaging2009;2:24-31

[31] Stelzmueller ME,Heinrich N,Laufer G.Concomitant transapical transcatheter aortic valve implantation and transapical mitral valve repair with neochord implantation..Innovations (Phila)2019;14:564-8

[32] Guerrero M,Himbert D,Eleid M.Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: Results from the first multicenter global registry..J Am Coll Cardiol Intv2016;9:1361-71

[33] Fanari Z,Nandish S.Simultaneous transcatheter transfemoral aortic and transseptal mitral valve replacement using Edward SAPIEN S3..Catheter Cardiovasc Interv2018;92:988-92

[34] Sannino A.Mitral regurgitation in patients with severe aortic stenosis: diagnosis and management..Heart2018;104:16-22

[35] Katte F,Jung C,Leistner D.Impact of concomitant mitral regurgitation on transvalvular gradient and flow in severe aortic stenosis: a systematic ex vivo analysis of a subentity of low-flow low-gradient aortic stenosis..EuroIntervention2018;13:1635-44

[36] Bruce CJ.Right-sided valve disease deserves a little more respect..Circulation2009;119:2726-34

[37] Kim HK,Park JS,Kim KB.Determinants of the severity of functional tricuspid regurgitation..Am J Cardiol2006;98:236-42

[38] Wilbring M,Ritzmann M,Schmidt T.Transcatheter aortic valve implantation reduces grade of concomitant mitral and tricuspid valve regurgitation and pulmonary hypertension..Eur J Cardiothorac Surg2014;46:818-24

[39] Lindman BR,Jaber WA,Mack MJ.Effect of tricuspid regurgitation and the right hear on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort..Circ Cardiovasc Interv2015;8:pii: e002073 PMCID:PMC4438083

[40] Takagi H,Kawai N.Impact of concurrent tricuspid regurgitation on mortality after transcatheter aortic-valve implantation..Catheter Cardiovasc Interv2019;93:946-53

[41] Pavasini R,Grapsa J,Tumscitz C.Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: a systematic review and meta-analysis..Eur Heart J Cardiovasc Imaging2018;19:654-9

[42] Barbanti M,Dvir D,Freeman M.Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement..Cathet Cardiovasc Intervent2015;85:677-84

[43] Reichart D,Deuschl F,Blankenberg S.Transcatheter tricuspid valve-in-ring and aortic valve-in-valve implantation..Thorac Cardiovasc Surg Rep2017;6:e29-31 PMCID:PMC5602643

[44] Sideris S,Oikonomopoulos G,Stavropoulos G.Left ventricular pacing through coronary sinus is feasible and safe for patients with prior tricuspid valve intervention..Pacing Clin Electrophysiol2016;39:378-81

[45] Faurie B,Wautot F,Champagnac D.Rapid pacing using the left ventricular guidewire: reviving an old technique to simplify BAV and TAVI procedures..Catheter Cardiovasc Interv2016;88:988-93

[46] Abdi S,Mandegar MH,Mortazavi SH.Single-session double valve replacement: TAVI + tricuspid valve-in-valve procedures..J Card Surg2019;34:518-21

[47] Kurra V,Roselli EE,Tuzcu EM.Prevalence of significant peripheral artery disease in patients evaluated for percutaneous aortic valve insertion: preprocedural assessment with multidetector computed tomography..J Thorac Cardiovasc Surg2009;137:1258-64

[48] Perlman GY,Pollak A,Alcalai R.Post-procedural hypertension following transcatheter aortic valve implantation: incidence and clinical significance..JACC Cardiovasc Interv2013;6:472-8

[49] Sato Y,Yahagi K,Kusuhara T.Simultaneous transcatheter aortic valve implantation and endovascular aneurysm repair in a patient with very severe aortic stenosis with abdominal aortic aneurysm..J Cardiol Cases2018;17:123-5 PMCID:PMC6149652

[50] Mauri S,Ferlini M,Gazzoli F.Combined transcatheter treatment of severe aortic valve stenosis and infrarenal abdominal aortic aneurysm in increased surgical risk patients..Ann Vasc Surg2019;60:480.e1-e5

[51] Natour M,Avraham E,Ronen Jaffe R.Combined urgent transcatheter aortic valve implantation and endovascular aneurysm repair for symptomatic abdominal aortic aneurysm..J Vasc Surg2018;68:e140

[52] Komlo CM,Bavaria JE,Anwaruddin S.Combined transaortic transcatheter valve replacement and thoracic endografting..Ann Thorac Surg2014;97:696-8

[53] Rylski B,Bavaria JE,Moser W.Development of a single endovascular device for aortic valve replacement and ascending aortic repair..J Card Surg2014;29:371-6

[54] Saadi EK,Almeida RMS.Endovascular treatment of the ascending aorta: is this the last frontier in aortic surgery?.Braz J Cardiovasc Surg2020;34:759-64 PMCID:PMC6894025

[55] Attinger-Toller A,Senn O,Shakir S.“One-stop shop”: safety of combining transcatheter aortic valve replacement and left atrial appendage occlusion..JACC Cardiovasc Interv2016;9:1487-95

[56] Biviano AB,Dizon J,Fleitman J.Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement: insights from the placement of aortic transcatheter valve (PARTNER) trial..Circ Cardiovasc Interv2016;9:e002766 PMCID:PMC4704130

[57] Nombela-Franco L,de Jaegere PP,Nuis RJ.Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation..Circulation2012;126:3041-53

[58] Yankelson L,Gershovitz L,Furer A.Atrial fibrillation, stroke, and mortality rates after transcatheter aortic valve implantation..Am J Cardiol2014;114:1861-6

[59] Stepinska J,Witkowski A,Chmielak Z.Risk factors for bleeding complications in patients undergoing transcatheter aortic valve implantation (TAVI)..Cardiol J2013;20:125-33

[60] Holmes DR,Turi ZG,Sievert H.Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial..Lancet2009;374:534-42

[61] Reddy VY,Miller MA,Schuler G.Left atrial appendage closure with the Watchman Device in patients with a contraindication for oral anticoagulation: the ASAP Study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)..J Am Coll Cardiol2013;61:2551-6

[62] Gafoor S,Franke J,Vaskelyte L.Transcatheter aortic valve replacement and left atrial appendage occlusion - a stitch in time?.Interv Cardiol2014;9:126-9 PMCID:PMC5808492

[63] Khattab AA,Sprecher B,Guerios E.Feasibility and outcomes of combined transcatheter aortic valve replacement with other structural heart interventions in a single session: a matched cohort study..Open Heart2014;1:e000014 PMCID:PMC4195934

[64] Handke M,Olschewski M,Geibel A.Patent foramen ovale and cryptogenic stroke in older patients..N Engl J Med2007;357:2262-8

[65] Saver JL,Thaler DE,MacDonald LA.Long-term outcomes of patent foramen ovale closure or medical therapy after stroke..N Engl J Med2017;377:1022-32

[66] Mas JL,Guillon B,Hosseini H.Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke..N Engl J Med2017;377:1011-21

[67] Taramasso M,Maisano F.Patent foramen ovale: indications for closure and techniques..EuroIntervention2016;12:X7-12

[68] Pasic M,D'Ancona G,Buz S.Transcatheter aortic valve implantation and simultaneous closure of ostium secundum atrial septal defect..Heart Surg Forum2011;14:E354-6

[69] Bao L,Chen S,Elhmidi Y.Feasibility and safety of combined percutaneous coronary intervention among high-risk patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis..Eur J Cardiothorac Surg2018;54:1052-9

[70] Gilhofer TS,Luescher TF.Simultaneous transcatheter aortic valve implantation and left atrial appendage occlusion versus both interventions as stand-alone procedures..Structural Heart2018;2:492-7